دورية أكاديمية

Implementation of HCV screening in the 1969–1989 birth‐cohort undergoing COVID‐19 vaccination.

التفاصيل البيبلوغرافية
العنوان: Implementation of HCV screening in the 1969–1989 birth‐cohort undergoing COVID‐19 vaccination.
المؤلفون: D'Ambrosio, Roberta, Rizzardini, Giuliano, Puoti, Massimo, Fagiuoli, Stefano, Anolli, Maria Paola, Gabiati, Claudia, D'Amico, Federico, Pasulo, Luisa, Restelli, Umberto, Colombo, Massimo, Lampertico, Pietro
المصدر: Liver International; May2022, Vol. 42 Issue 5, p1012-1016, 5p, 1 Chart
مصطلحات موضوعية: COVID-19 vaccines, MEDICAL screening, HEPATITIS C virus, YOUNG adults, TREATMENT programs
مصطلحات جغرافية: ITALY, NORTHERN Italy, LOMBARDY (Italy)
الشركة/الكيان: WORLD Health Organization
مستخلص: Background and Aim: The World Health Organization (WHO) goal of hepatitis C virus (HCV) elimination by 2030 relies on the scaling‐up of both identification and linkage to care of the infected population, worldwide. In Italy, the estimated burden of HCV carriers who are unaware of their infection amounts to 200 000 persons, a projection that reinforces the need for broadening population access to effective screening programmes. Methods: A pivotal screening programme targeting subjects born between 1969 and 1989 has been conducted in Lombardy, Northern Italy, where point‐of‐care (POC) testing was offered for free concomitantly to COVID‐19 vaccination. Results: Amongst 7219 subjects born between 1969 and 1989 who underwent HCV screening through POC, 7 (0.10%) subjects tested anti‐HCV positive: 5 (0.07%) had confirmed anti‐HCV positivity (Table 1) and 4 of them (0.05%) were HCV‐RNA positive by standard confirmation tests. Conclusions: This pivotal study demonstrated the feasibility of a POC‐based anti‐HCV screening programme in young adults undergoing COVID‐19 vaccination. The prevalence of HCV infection in subjects born in the 1969–1989 cohort in Italy seems to be lower than previously estimated. Whether the extension of this programme to subjects born before 1969 could lead to improved screening effectiveness should be a matter of debate. [ABSTRACT FROM AUTHOR]
Copyright of Liver International is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14783223
DOI:10.1111/liv.15216